The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility
The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility
复制标题
DOI：
10.1186/1477-7517-5-32
复制
发表时间：
2008-01-01
影响因子：
4.4
通讯作者：
Kerr, Thomas
中科院分区：
文献类型：
--
作者：
Fast, Danya;Small, Will;Kerr, Thomas
背景：不安全注射做法在注射吸毒者（IDU）中普遍存在，并导致多种形式的药物相关伤害，包括艾滋病毒/丙型肝炎病毒传播和其他细菌和病毒感染。北美第一个监督注射设施（SIF）在温哥华建立，以解决注射u中与注射有关的危害。本研究旨在检查注射吸毒者在SIF背景下接受更安全注射教育的经历。方法：对从SIF使用者队列（即监督注射科学评估（SEOSI）队列）中招募的50名个体进行半结构化定性访谈。录音访谈引出了IDU对在SIF范围内提供更安全注射教育的看法。采访被逐字记录下来，并进行了专题分析。结果：参与者的叙述表明，当地注射吸毒者在安全注射做法方面存在着巨大的知识缺口，这些知识缺口导致了不安全的注射做法和负面的健康后果。然而，IDU的观点表明，SIF允许客户通过该机构特有的一些机制来识别和解决这些知识差距，包括作为吸毒周期的一部分而不是在吸毒周期之外进行的有针对性的教育信息传递，在客户遇到困难时进行的更安全注射技术的现场演示，以及增加寻求“专家”医疗保健专业人员帮助的机会。重要的是，研究参与者指出，随着时间的推移，SIF的整体环境促进了设施内外采用更安全的注射方法。结论：我们得出结论，SIF在向活跃的IDU人群传播针对不安全和不卫生注射做法的教育信息方面特别有效。与之前的工作一致，本研究的结果表明，SIFs代表了一种独特的“微环境”，可以促进减少许多与药物相关的危害。
Background: Unsafe injection practices are prevalent among injection drug users (IDU) and have resulted in numerous forms of drug-related harm including HIV/HCV transmission and other bacterial and viral infections. North America's first supervised injection facility (SIF) was established in Vancouver in order to address injection-related harms among IDU. This study sought to examine injection drug users' experiences receiving safer injecting education in the context of a SIF.Methods: Semi-structured qualitative interviews were conducted with 50 individuals recruited from a cohort of SIF users known as the Scientific Evaluation of Supervised Injection (SEOSI) cohort. Audio recorded interviews elicited IDU perspectives regarding the provision of safer injecting education within the context of a SIF. Interviews were transcribed verbatim and a thematic analysis was conducted.Results: Participant narratives indicate that significant gaps in knowledge regarding safer injecting practices exist among local IDU, and that these knowledge deficits result in unsafe injecting practices and negative health outcomes. However, IDU perspectives reveal that the SIF allows clients to identify and address these gaps in knowledge through a number of mechanisms that are unique to this facility, including targeted educational messaging that occurs as a part of the drug use cycle and not outside of it, in situ demonstration of safer injecting techniques that takes place the moment a client is experiencing difficulties, and enhanced opportunities to seek help from 'expert' healthcare professionals. Importantly, study participants indicated that the overall environment of the SIF promotes the adoption of safer injecting practices over time, both within and outside of the facility.Conclusion: We conclude that the SIF has been particularly effective in transmitting educational messages targeting unsafe and unhygienic injection practices to a population of active IDU. Consistent with previous work, results of this study indicate that SIFs represent a unique 'microenvironment' that can facilitate the reduction of numerous drug related harms.